
EquityEquity - OtherVery High Risk
NAV (18-Nov-25)
Returns (Since Inception)
Fund Size
₹432 Cr
Expense Ratio
0.47%
ISIN
INF769K01KU7
Minimum SIP
-
Exit Load
-
Inception Date
23 Oct 2023
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+1.72%
— (Cat Avg.)
Since Inception
+23.18%
— (Cat Avg.)
| Equity | ₹432.14 Cr | 100.03% |
| Others | ₹-0.12 Cr | -0.03% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| BSE Ltd | Equity | ₹25.3 Cr | 5.86% |
| Coforge Ltd | Equity | ₹23.27 Cr | 5.39% |
| One97 Communications Ltd | Equity | ₹22.89 Cr | 5.30% |
| Fortis Healthcare Ltd | Equity | ₹22.58 Cr | 5.23% |
| Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹19.56 Cr | 4.53% |
| Max Financial Services Ltd | Equity | ₹19.49 Cr | 4.51% |
| Muthoot Finance Ltd | Equity | ₹16.3 Cr | 3.77% |
| Bharat Electronics Ltd | Equity | ₹15.98 Cr | 3.70% |
| Solar Industries India Ltd | Equity | ₹15.93 Cr | 3.69% |
| Eternal Ltd | Equity | ₹15.79 Cr | 3.65% |
| Dixon Technologies (India) Ltd | Equity | ₹15.39 Cr | 3.56% |
| HDFC Asset Management Co Ltd | Equity | ₹14.92 Cr | 3.45% |
| Eicher Motors Ltd | Equity | ₹14.49 Cr | 3.35% |
| Bajaj Finance Ltd | Equity | ₹14.09 Cr | 3.26% |
| Bosch Ltd | Equity | ₹13.32 Cr | 3.08% |
| Indian Hotels Co Ltd | Equity | ₹12.7 Cr | 2.94% |
| UPL Ltd | Equity | ₹12.55 Cr | 2.91% |
| Divi's Laboratories Ltd | Equity | ₹12.53 Cr | 2.90% |
| Bharti Airtel Ltd | Equity | ₹12.21 Cr | 2.83% |
| TVS Motor Co Ltd | Equity | ₹12.17 Cr | 2.82% |
| Indian Bank | Equity | ₹11.95 Cr | 2.77% |
| Aditya Birla Capital Ltd | Equity | ₹11.85 Cr | 2.74% |
| Maruti Suzuki India Ltd | Equity | ₹11.17 Cr | 2.58% |
| Mahindra & Mahindra Ltd | Equity | ₹10.84 Cr | 2.51% |
| L&T Finance Ltd | Equity | ₹10.54 Cr | 2.44% |
| InterGlobe Aviation Ltd | Equity | ₹10.4 Cr | 2.41% |
| HDFC Bank Ltd | Equity | ₹10.23 Cr | 2.37% |
| Mazagon Dock Shipbuilders Ltd | Equity | ₹9.91 Cr | 2.29% |
| SBI Cards and Payment Services Ltd Ordinary Shares | Equity | ₹7.35 Cr | 1.70% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹6.43 Cr | 1.49% |
| Net Receivables / (Payables) | Cash | ₹-0.12 Cr | 0.03% |
| Treps | Cash - Repurchase Agreement | ₹0.01 Cr | 0.00% |
Large Cap Stocks
45.83%
Mid Cap Stocks
54.19%
Small Cap Stocks
--
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Financial Services | ₹142.02 Cr | 32.87% |
| Consumer Cyclical | ₹90.48 Cr | 20.94% |
| Technology | ₹61.55 Cr | 14.25% |
| Healthcare | ₹61.1 Cr | 14.14% |
| Industrials | ₹36.3 Cr | 8.40% |
| Basic Materials | ₹28.48 Cr | 6.59% |
| Communication Services | ₹12.21 Cr | 2.83% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better

Since October 2023
Since March 2025
ISIN INF769K01KU7 | Expense Ratio 0.47% | Exit Load - | Fund Size ₹432 Cr | Age 2 years | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty 200 Alpha 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹2,14,063 Cr
Address
Unit No. 606, 6th Floor, Mumbai, 400 098
Your principal amount will be at Very High Risk


EquityEquity - OtherVery High Risk
NAV (18-Nov-25)
Returns (Since Inception)
Fund Size
₹432 Cr
Expense Ratio
0.47%
ISIN
INF769K01KU7
Minimum SIP
-
Exit Load
-
Inception Date
23 Oct 2023
Your principal amount will be at Very High Risk

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+1.72%
— (Cat Avg.)
Since Inception
+23.18%
— (Cat Avg.)
| Equity | ₹432.14 Cr | 100.03% |
| Others | ₹-0.12 Cr | -0.03% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| BSE Ltd | Equity | ₹25.3 Cr | 5.86% |
| Coforge Ltd | Equity | ₹23.27 Cr | 5.39% |
| One97 Communications Ltd | Equity | ₹22.89 Cr | 5.30% |
| Fortis Healthcare Ltd | Equity | ₹22.58 Cr | 5.23% |
| Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹19.56 Cr | 4.53% |
| Max Financial Services Ltd | Equity | ₹19.49 Cr | 4.51% |
| Muthoot Finance Ltd | Equity | ₹16.3 Cr | 3.77% |
| Bharat Electronics Ltd | Equity | ₹15.98 Cr | 3.70% |
| Solar Industries India Ltd | Equity | ₹15.93 Cr | 3.69% |
| Eternal Ltd | Equity | ₹15.79 Cr | 3.65% |
| Dixon Technologies (India) Ltd | Equity | ₹15.39 Cr | 3.56% |
| HDFC Asset Management Co Ltd | Equity | ₹14.92 Cr | 3.45% |
| Eicher Motors Ltd | Equity | ₹14.49 Cr | 3.35% |
| Bajaj Finance Ltd | Equity | ₹14.09 Cr | 3.26% |
| Bosch Ltd | Equity | ₹13.32 Cr | 3.08% |
| Indian Hotels Co Ltd | Equity | ₹12.7 Cr | 2.94% |
| UPL Ltd | Equity | ₹12.55 Cr | 2.91% |
| Divi's Laboratories Ltd | Equity | ₹12.53 Cr | 2.90% |
| Bharti Airtel Ltd | Equity | ₹12.21 Cr | 2.83% |
| TVS Motor Co Ltd | Equity | ₹12.17 Cr | 2.82% |
| Indian Bank | Equity | ₹11.95 Cr | 2.77% |
| Aditya Birla Capital Ltd | Equity | ₹11.85 Cr | 2.74% |
| Maruti Suzuki India Ltd | Equity | ₹11.17 Cr | 2.58% |
| Mahindra & Mahindra Ltd | Equity | ₹10.84 Cr | 2.51% |
| L&T Finance Ltd | Equity | ₹10.54 Cr | 2.44% |
| InterGlobe Aviation Ltd | Equity | ₹10.4 Cr | 2.41% |
| HDFC Bank Ltd | Equity | ₹10.23 Cr | 2.37% |
| Mazagon Dock Shipbuilders Ltd | Equity | ₹9.91 Cr | 2.29% |
| SBI Cards and Payment Services Ltd Ordinary Shares | Equity | ₹7.35 Cr | 1.70% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹6.43 Cr | 1.49% |
| Net Receivables / (Payables) | Cash | ₹-0.12 Cr | 0.03% |
| Treps | Cash - Repurchase Agreement | ₹0.01 Cr | 0.00% |
Large Cap Stocks
45.83%
Mid Cap Stocks
54.19%
Small Cap Stocks
--
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Financial Services | ₹142.02 Cr | 32.87% |
| Consumer Cyclical | ₹90.48 Cr | 20.94% |
| Technology | ₹61.55 Cr | 14.25% |
| Healthcare | ₹61.1 Cr | 14.14% |
| Industrials | ₹36.3 Cr | 8.40% |
| Basic Materials | ₹28.48 Cr | 6.59% |
| Communication Services | ₹12.21 Cr | 2.83% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better

Since October 2023
Since March 2025
ISIN INF769K01KU7 | Expense Ratio 0.47% | Exit Load - | Fund Size ₹432 Cr | Age 2 years | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty 200 Alpha 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹2,14,063 Cr
Address
Unit No. 606, 6th Floor, Mumbai, 400 098
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments